Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma

Veterans Affairs Medical Center - Miami, Miami

Rush Cancer Institute, Chicago

Washington University School of Medicine, St Louis

Tulane University School of Medicine, New Orleans

Arlington Cancer Center, Arlington

Beth Israel Deaconess Medical Center, Boston

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

Hahnemann University Hospital, Philadelphia

University of Pittsburgh Cancer Institute, Pittsburgh

Vanderbilt-Ingram Cancer Center, Nashville

University of Texas - MD Anderson Cancer Center, Houston